121 related articles for article (PubMed ID: 38415712)
1. Genital chronic graft-versus-host disease: an unmet need that requires trained gynecologists.
Martínez-Maestre MÁ; Castelo-Branco C; Calderón AM; Espigado I; Pérez-Simón JA; González-Cejudo C
Climacteric; 2024 Jun; 27(3):275-281. PubMed ID: 38415712
[TBL] [Abstract][Full Text] [Related]
2. Genital chronic graft-versus-host disease in females: a cross-sectional study.
Smith Knutsson E; Björk Y; Broman AK; Helström L; Levin Jakobsen AM; Nilsson O; Sundfeldt K; Brune M
Biol Blood Marrow Transplant; 2014 Jun; 20(6):806-11. PubMed ID: 24594123
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of female genital chronic graft-versus-host disease symptoms, signs, diagnosis and treatment.
Smith Knutsson E; Björk Y; Broman AK; Helström L; Nicklasson M; Brune M; Sundfeldt K
Acta Obstet Gynecol Scand; 2018 Sep; 97(9):1122-1129. PubMed ID: 29752810
[TBL] [Abstract][Full Text] [Related]
4. Female genital chronic graft-versus-host disease: importance of early diagnosis to avoid severe complications.
Hirsch P; Leclerc M; Rybojad M; Petropoulou AD; Robin M; Ribaud P; de la Tour RP; Cavelier-Balloy B; Socié G; Vexiau-Robert D
Transplantation; 2012 Jun; 93(12):1265-9. PubMed ID: 22466789
[TBL] [Abstract][Full Text] [Related]
5. Late follow-up of genital and ophthalmologic chronic graft-vs-host disease in females after allogeneic stem cell transplantation.
Smith Knutsson E; Nicklasson M; Björk Y; Stenberg K; Sundfeldt K; Brune M
Acta Obstet Gynecol Scand; 2022 Mar; 101(3):364-373. PubMed ID: 34962288
[TBL] [Abstract][Full Text] [Related]
6. Genital chronic GVHD in men after hematopoietic stem cell transplantation: a single-center cross-sectional analysis of 155 patients.
Mueller SM; Haeusermann P; Rovó A; Halter JP; Passweg J; Itin P; Tichelli A
Biol Blood Marrow Transplant; 2013 Nov; 19(11):1574-80. PubMed ID: 23962394
[TBL] [Abstract][Full Text] [Related]
7. Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease.
Fall-Dickson JM; Mitchell SA; Marden S; Ramsay ES; Guadagnini JP; Wu T; St John L; Pavletic SZ;
Biol Blood Marrow Transplant; 2010 Jul; 16(7):948-956. PubMed ID: 20139026
[TBL] [Abstract][Full Text] [Related]
8. Psychological and physical function in allogeneic hematopoietic cell transplant survivors with chronic graft-versus-host disease.
Hansen JL; Juckett MB; Foster MA; Rumble ME; Morris KE; Hematti P; Costanzo ES
J Cancer Surviv; 2023 Jun; 17(3):646-656. PubMed ID: 36917433
[TBL] [Abstract][Full Text] [Related]
9. Inert Gas Washout in Bronchiolitis Obliterans Following Hematopoietic Cell Transplantation.
Nyilas S; Baumeler L; Tamm M; Halter JP; Savic S; Korten I; Meyer A; Singer F; Passweg JR; Latzin P; Stolz D
Chest; 2018 Jul; 154(1):157-168. PubMed ID: 29275133
[TBL] [Abstract][Full Text] [Related]
10. Early Diagnosis of Labial Fusion in Women After Allogeneic Hematopoietic Cell Transplant Enables Outpatient Treatment.
Scrivani C; Merideth MA; Klepac Pulanic T; Pavletic S; Childs RW; Hsieh MM; Stratton P
J Low Genit Tract Dis; 2017 Apr; 21(2):157-160. PubMed ID: 27977542
[TBL] [Abstract][Full Text] [Related]
11. Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation.
Herzberg PY; Heussner P; Mumm FH; Horak M; Hilgendorf I; von Harsdorf S; Hemmati P; Rieger K; Greinix H; Freund M; Lee SJ; Holler E; Wolff D
Biol Blood Marrow Transplant; 2010 Dec; 16(12):1707-17. PubMed ID: 20541028
[TBL] [Abstract][Full Text] [Related]
12. A survey of fertility and sexual health following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia.
Dyer G; Gilroy N; Bradford J; Brice L; Kabir M; Greenwood M; Larsen SR; Moore J; Hertzberg M; Kwan J; Brown L; Hogg M; Huang G; Tan J; Ward C; Kerridge I
Br J Haematol; 2016 Feb; 172(4):592-601. PubMed ID: 26847746
[TBL] [Abstract][Full Text] [Related]
13. Graft-Versus-Host-Disease and Health-Related Quality of Life in Young Long-term Survivors of Cancer and Allogeneic Hematopoietic Stem Cell Transplantation.
Diep PP; Rueegg CS; Burman MM; Brinch L; Bø K; Fosså K; Landrø L; Loge JH; Lund MB; Massey RJ; Myrdal OH; Pathak M; Rimstad L; Tanem KE; Tjønnfjord GE; Aaløkken TM; Ruud E
J Adolesc Young Adult Oncol; 2023 Feb; 12(1):66-75. PubMed ID: 35544321
[No Abstract] [Full Text] [Related]
14. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.
Grube M; Holler E; Weber D; Holler B; Herr W; Wolff D
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1781-1791. PubMed ID: 27343720
[TBL] [Abstract][Full Text] [Related]
15. The management of gynecological complications in long-term survivors after allogeneic hematopoietic cell transplantation-a single-center real-life experience.
Klasa Ł; Sadowska-Klasa A; Piekarska A; Wydra D; Zaucha JM
Ann Hematol; 2020 Jun; 99(6):1361-1368. PubMed ID: 32342133
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Cutaneous Disease Severity Estimates on Survival Outcomes in Patients With Chronic Graft-vs-Host Disease.
Baumrin E; Baker LX; Byrne M; Martin PJ; Flowers ME; Onstad L; El Jurdi N; Chen H; Beeghly-Fadiel A; Lee SJ; Tkaczyk ER
JAMA Dermatol; 2023 Apr; 159(4):393-402. PubMed ID: 36884224
[TBL] [Abstract][Full Text] [Related]
17. Incidence, Risk Factors, Characteristics, and Outcome of Chronic Graft Versus Host Disease in Children Undergoing Haploidentical Peripheral Blood Stem Cell Transplant With Post-transplant Cyclophosphamide.
Arora S; Thakkar D; Upasana K; Yadav A; Rastogi N; Sharma PS; Yadav SP
J Pediatr Hematol Oncol; 2024 Jan; 46(1):e44-e50. PubMed ID: 37983773
[TBL] [Abstract][Full Text] [Related]
18. Female genital tract chronic graft-versus-host disease: review of the literature.
Ciavattini A; Clemente N
Anticancer Res; 2015 Jan; 35(1):13-7. PubMed ID: 25550529
[TBL] [Abstract][Full Text] [Related]
19. Impact of Center Volume on Chronic Graft Versus Host Disease in Patients With Allogeneic Stem Cell Transplantation.
Shimomura Y; Kitamura T; Murata M; Matsuo K; Ito Y; Ichinohe T; Hashii Y; Goto H; Kato K; Ishimaru F; Sato A; Onizuka M; Yanagisawa A; Ohbiki M; Tabuchi K; Atsuta Y; Fukuda T; Kanda J; Terakura S
Transplant Cell Ther; 2024 Mar; 30(3):326.e1-326.e14. PubMed ID: 38218451
[TBL] [Abstract][Full Text] [Related]
20. IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.
Kattner AS; Holler E; Holler B; Klobuch S; Weber D; Martinovic D; Edinger M; Herr W; Wolff D
Ann Hematol; 2020 Apr; 99(4):847-853. PubMed ID: 32086584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
